Lepixa 500/Lepixa 1000/Lepixa Indications/Uses

Lepixa 500/Lepixa 1000: Monotherapy in the treatment of partial onset seizures with or without secondary generalization in patients from 16 years with newly diagnosed epilepsy.
As adjunctive therapy in the treatment of partial onset seizures with or without secondary generalization in adults and children from 4 years with epilepsy; myoclonic seizures in adults and adolescents from 12 years with juvenile myoclonic epilepsy.
Also as adjunctive therapy for patients ≥4 years with Primary Generalized Tonic, Clonic Seizure (PGTCS).
Lepixa: Oral Solution: Levetiracetam Oral Solution is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.
Levetiracetam Oral Solution is indicated as adjunctive therapy: In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 1 month of age with epilepsy.
In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
Levetiracetam Oral Solution concentrate is an alternative for patients (adults and children from 4 years of age) when oral administration is temporarily not feasible.
Solution for injection: Partial Onset Seizures: Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. Levetiracetam injection is for intravenous use only as an alternative for patients when oral administration is temporarily is not feasible.
Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy: Levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. Levetiracetam injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible.
Primary Generalized Tonic-Clonic Seizures: Levetiracetam is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. Levetiracetam injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible.